OncoCyte (OCX) Earnings Date, Estimates & Call Transcripts → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free OCX Stock Alerts $2.89 -0.01 (-0.34%) (As of 05/15/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueOCX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OCX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects OncoCyte Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.91) EPS OncoCyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/9/2023Q3 2023($1.52)($0.57)+$0.95($0.33)$0.40 million$0.43 million8/10/2023Q2 2023($2.60)($1.07)+$1.53($1.07)$0.60 million$0.46 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($2.00)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($2.00)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($2.00)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 millionHealthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic5/11/2023Q1 2023($2.40)($0.80)+$1.60($0.10)$0.50 million$0.30 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($1.60)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($1.60)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($1.60)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million11/10/2022Q3 2022($2.60)($1.60)+$1.00($0.08)$1.50 million$1.02 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($1.40)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($1.40)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($1.40)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 millionTiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are.8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million8/10/2022Q2 2022($2.60)($1.40)+$1.20($0.07)$2.50 million$2.07 million 5/11/2022Q1 2022($2.60)($2.20)+$0.40($2.20)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($2.20)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($2.20)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 millionTop 5 AI Stocks to Buy for 2024 (Ad)5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million5/11/2022Q1 2022($2.60)($2.20)+$0.40($0.11)$1.70 million$1.43 million 3/10/2022Q4 2021($2.00)($2.40)($0.40)$3.00$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$3.00$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$3.00$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 millionThis unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million3/10/2022Q4 2021($2.00)($2.40)($0.40)$0.15$4.35 million$3.59 million 11/9/2021Q3 2021($1.40)($2.60)($1.20)($2.20)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($2.20)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($2.20)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($1.40)($2.60)($1.20)($0.11)$3.20 million$0.98 million11/9/2021Q3 2021($2.40)($3.00)($0.60)($0.11)$3.20 million$0.98 million 8/10/2021Q2 2021($1.60)($2.20)($0.60)($2.00)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($2.00)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($2.00)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/10/2021Q2 2021($1.60)($2.20)($0.60)($0.10)$1.65 million$2.03 million8/9/2021Q2 2021($2.00)($2.40)($0.40)($0.10)$1.65 million$2.03 million 5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.60)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.60)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.60)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/17/2021Q1 2021($1.80)($0.80)+$1.00($0.03)$0.91 million$1.12 million5/16/2021Q1 2021($2.00)($1.00)+$1.00($0.03)$0.91 million$1.12 million OncoCyte Earnings - Frequently Asked Questions How much revenue does OncoCyte generate each year? OncoCyte (NASDAQ:OCX) has a recorded annual revenue of $1.50 million. How much profit does OncoCyte generate each year? OncoCyte (NASDAQ:OCX) has a recorded net income of -$27.78 million. OCX has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: CDIO Earnings TRIB Earnings ACHL Earnings BMRA Earnings AWH Earnings DRRX Earnings MYMD Earnings ICCC Earnings ABIO Earnings VNRX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:OCX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
